What we offer start-ups: For clinical trials in Phase I–IV, we offer the following services: consulting, project management and monitoring, regulatory affairs, medical writing, medical safety, data management, and statistics. We are particularly flexible when working with smaller clients and startups: We strive to offer customised solutions for conducting clinical trials – even if the underlying assumptions change over the course of the project. We place great emphasis on transparency and close collaboration on an equal footing. Thanks to our experience and established processes, which allow for a high degree of flexibility, we can implement necessary changes quickly and efficiently, thereby ensuring that the results meet the client’s requirements throughout the entire collaboration. We take a sponsor-focused approach that is based on responsiveness and proactivity and provides optimal support, particularly for small companies that are new to clinical development.

What we offer investors: A clinical CRO for their portfolio companies that is characterised by stability, financial independence, and outstanding quality.

LinkedIn account of the company: www.linkedin.com/company/fgk-clinical-research-gmbh